Ferrer Isidro, Garcia-Esparcia Paula, Carmona Margarita, Carro Eva, Aronica Eleonora, Kovacs Gabor G, Grison Alice, Gustincich Stefano
Institute of Neuropathology, Bellvitge University Hospital, Hospitalet de Llobregat, University of BarcelonaBarcelona, Spain; Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED)Madrid, Spain; Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de LlobregatBarcelona, Spain.
Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED)Madrid, Spain; Neuroscience Group, Research Institute HospitalMadrid, Spain.
Front Aging Neurosci. 2016 Jul 5;8:163. doi: 10.3389/fnagi.2016.00163. eCollection 2016.
Olfactory receptors (ORs) and down-stream functional signaling molecules adenylyl cyclase 3 (AC3), olfactory G protein α subunit (Gαolf), OR transporters receptor transporter proteins 1 and 2 (RTP1 and RTP2), receptor expression enhancing protein 1 (REEP1), and UDP-glucuronosyltransferases (UGTs) are expressed in neurons of the human and murine central nervous system (CNS). In vitro studies have shown that these receptors react to external stimuli and therefore are equipped to be functional. However, ORs are not directly related to the detection of odors. Several molecules delivered from the blood, cerebrospinal fluid, neighboring local neurons and glial cells, distant cells through the extracellular space, and the cells' own self-regulating internal homeostasis can be postulated as possible ligands. Moreover, a single neuron outside the olfactory epithelium expresses more than one receptor, and the mechanism of transcriptional regulation may be different in olfactory epithelia and brain neurons. OR gene expression is altered in several neurodegenerative diseases including Parkinson's disease (PD), Alzheimer's disease (AD), progressive supranuclear palsy (PSP) and sporadic Creutzfeldt-Jakob disease (sCJD) subtypes MM1 and VV2 with disease-, region- and subtype-specific patterns. Altered gene expression is also observed in the prefrontal cortex in schizophrenia with a major but not total influence of chlorpromazine treatment. Preliminary parallel observations have also shown the presence of taste receptors (TASRs), mainly of the bitter taste family, in the mammalian brain, whose function is not related to taste. TASRs in brain are also abnormally regulated in neurodegenerative diseases. These seminal observations point to the need for further studies on ORs and TASRs chemoreceptors in the mammalian brain.
嗅觉受体(ORs)以及下游功能信号分子腺苷酸环化酶3(AC3)、嗅觉G蛋白α亚基(Gαolf)、OR转运体受体转运蛋白1和2(RTP1和RTP2)、受体表达增强蛋白1(REEP1)和尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)在人和小鼠中枢神经系统(CNS)的神经元中表达。体外研究表明,这些受体对外界刺激有反应,因此具备发挥功能的能力。然而,ORs与气味检测并无直接关联。可以假定,从血液、脑脊液、邻近的局部神经元和神经胶质细胞、通过细胞外空间传递的远处细胞以及细胞自身的自我调节内环境稳态中释放出的几种分子可能是潜在配体。此外,嗅觉上皮外的单个神经元表达不止一种受体,并且嗅觉上皮和脑神经元中的转录调控机制可能有所不同。在包括帕金森病(PD)、阿尔茨海默病(AD)、进行性核上性麻痹(PSP)以及散发性克雅氏病(sCJD)的MM1和VV2亚型等几种神经退行性疾病中,OR基因表达会发生改变,且具有疾病、区域和亚型特异性模式。在精神分裂症患者的前额叶皮质中也观察到基因表达的改变,氯丙嗪治疗有主要但并非完全的影响。初步的平行观察还表明,哺乳动物大脑中存在味觉受体(TASRs),主要是苦味家族的味觉受体,其功能与味觉无关。大脑中的TASRs在神经退行性疾病中也受到异常调控。这些开创性的观察结果表明,有必要对哺乳动物大脑中的ORs和TASRs化学感受器进行进一步研究。